Cargando…
A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis
BACKGROUND: Most of the current anti-fungal treatments are chemical-based, fungistatic, have low efficacy in the treatment of tinea and toxicity concerns, while onychomycosis remains recalcitrant to most antifungal therapies. The study aimed to establish the fungicidal, efficacy and safety profile o...
Autores principales: | Parekh, Manoj, Ramaiah, Girisha, Pashilkar, Prachi, Ramanujam, Ranjani, Johnston, Peter, Ilag, Leodevico L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604504/ https://www.ncbi.nlm.nih.gov/pubmed/28923039 http://dx.doi.org/10.1186/s12906-017-1970-2 |
Ejemplares similares
-
Efficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris
por: Choudhary, Sanjiv V., et al.
Publicado: (2014) -
Are Long-Chain Polyunsaturated Fatty Acids the Link between the Immune System and the Microbiome towards Modulating Cancer?
por: Ilag, Leodevico L.
Publicado: (2018) -
Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial
por: Choudhary, SV, et al.
Publicado: (2013) -
Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris
por: Das, Sudip, et al.
Publicado: (2010) -
A step in the right direction: the evidence for treating of tinea pedis and onychomycosis in people with diabetes
por: Matricciani, Lisa, et al.
Publicado: (2011)